BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16801463)

  • 1. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data.
    Healey JS; Toff WD; Lamas GA; Andersen HR; Thorpe KE; Ellenbogen KA; Lee KL; Skene AM; Schron EB; Skehan JD; Goldman L; Roberts RS; Camm AJ; Yusuf S; Connolly SJ
    Circulation; 2006 Jul; 114(1):11-7. PubMed ID: 16801463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.
    Connolly SJ; Kerr CR; Gent M; Roberts RS; Yusuf S; Gillis AM; Sami MH; Talajic M; Tang AS; Klein GJ; Lau C; Newman DM
    N Engl J Med; 2000 May; 342(19):1385-91. PubMed ID: 10805823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease.
    Sweeney MO; Bank AJ; Nsah E; Koullick M; Zeng QC; Hettrick D; Sheldon T; Lamas GA;
    N Engl J Med; 2007 Sep; 357(10):1000-8. PubMed ID: 17804844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
    Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction.
    Lamas GA; Lee KL; Sweeney MO; Silverman R; Leon A; Yee R; Marinchak RA; Flaker G; Schron E; Orav EJ; Hellkamp AS; Greer S; McAnulty J; Ellenbogen K; Ehlert F; Freedman RA; Estes NA; Greenspon A; Goldman L;
    N Engl J Med; 2002 Jun; 346(24):1854-62. PubMed ID: 12063369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome.
    Nielsen JC; Thomsen PE; Højberg S; Møller M; Vesterlund T; Dalsgaard D; Mortensen LS; Nielsen T; Asklund M; Friis EV; Christensen PD; Simonsen EH; Eriksen UH; Jensen GV; Svendsen JH; Toff WD; Healey JS; Andersen HR;
    Eur Heart J; 2011 Mar; 32(6):686-96. PubMed ID: 21300730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pacing therapy for prevention of atrial fibrillation.
    Ellenbogen KA
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S84-7. PubMed ID: 17336892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of ventricular pacing burden and atrial pacing therapies on the progression of atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials.
    Munawar DA; Mahajan R; Agbaedeng TA; Thiyagarajah A; Twomey DJ; Khokhar K; O'Shea C; Young GD; Roberts-Thomson KC; Munawar M; Lau DH; Sanders P
    Heart Rhythm; 2019 Aug; 16(8):1204-1214. PubMed ID: 30772532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interatrial septal pacing to suppress atrial fibrillation in patients with dual chamber pacemakers: A meta-analysis of randomized, controlled trials.
    Shali S; Su Y; Ge J
    Int J Cardiol; 2016 Sep; 219():421-7. PubMed ID: 27371866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias.
    Funck RC; Boriani G; Manolis AS; Püererfellner H; Mont L; Tukkie R; Pisapia A; Israel CW; Grovale N; Grammatico A; Padeletti L;
    Am Heart J; 2008 Sep; 156(3):445-51. PubMed ID: 18760124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta-analysis.
    Shurrab M; Healey JS; Haj-Yahia S; Kaoutskaia A; Boriani G; Carrizo A; Botto G; Newman D; Padeletti L; Connolly SJ; Crystal E
    Europace; 2017 Feb; 19(2):282-288. PubMed ID: 28175255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on clinical trials in pacing: is dual chamber pacing better?
    Hussein SJ; Hennekens CH; Lamas GA
    Curr Opin Cardiol; 2004 Jan; 19(1):12-8. PubMed ID: 14688628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA;
    Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.
    Knight BP; Gersh BJ; Carlson MD; Friedman PA; McNamara RL; Strickberger SA; Tse HF; Waldo AL; ; ; ;
    Circulation; 2005 Jan; 111(2):240-3. PubMed ID: 15657388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials.
    Bradley DJ; Shen WK
    Heart Rhythm; 2007 Feb; 4(2):224-32. PubMed ID: 17275763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial-based pacing has no benefit over ventricular pacing in preventing atrial arrhythmias in adults with congenital heart disease.
    Opic P; Yap SC; Van Kranenburg M; Van Dijk AP; Budts W; Vliegen HW; Van Erven L; Can A; Sahin G; De Groot NM; Witsenburg M; Roos-Hesselink JW
    Europace; 2013 Dec; 15(12):1757-62. PubMed ID: 23851513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) Study.
    Lau CP; Tachapong N; Wang CC; Wang JF; Abe H; Kong CW; Liew R; Shin DG; Padeletti L; Kim YH; Omar R; Jirarojanakorn K; Kim YN; Chen MC; Sriratanasathavorn C; Munawar M; Kam R; Chen JY; Cho YK; Li YG; Wu SL; Bailleul C; Tse HF;
    Circulation; 2013 Aug; 128(7):687-93. PubMed ID: 23868858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome.
    Andersen HR; Nielsen JC; Thomsen PE; Thuesen L; Mortensen PT; Vesterlund T; Pedersen AK
    Lancet; 1997 Oct; 350(9086):1210-6. PubMed ID: 9652562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.